| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Athira Pharma, Inc. | Director | Stock Option (Right to Buy) | 20.9K | 30 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | 30 May 2025 | 1 | $0 | 4 | Director | 03 Jun 2025, 17:34 |
| ARYD | ARYA Sciences Acquisition Corp IV | 31 Jul 2024 | 0 | $0 | 4 | Director | 31 Jul 2024, 21:45 |
| PCSC | Perceptive Capital Solutions Corp | 11 Jun 2024 | 0 | $0 | 3 | Director | 11 Jun 2024, 17:58 |
| ATHA | Athira Pharma, Inc. | 24 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 19:01 |
| ATHA | Athira Pharma, Inc. | 19 May 2023 | 1 | $0 | 4 | Director | 22 May 2023, 18:04 |
| ATHA | Athira Pharma, Inc. | 20 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 17:45 |
| ARYE | ARYA Sciences Acquisition Corp V | 12 Jul 2021 | 0 | $0 | 3 | Director | 12 Jul 2021, 20:12 |
| ATHA | Athira Pharma, Inc. | 28 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 18:06 |